Christopher Upton

Array ( [id] => 6711089 [patent_doc_number] => 20030170838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Novel polynucleotides and polypeptides encoded thereby' [patent_app_type] => new [patent_app_number] => 09/954342 [patent_app_country] => US [patent_app_date] => 2001-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70761 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20030170838.pdf [firstpage_image] =>[orig_patent_app_number] => 09954342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1068630 [patent_doc_number] => 06844156 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-01-18 [patent_title] => 'Methods for identifying a preferred liver transplant donor' [patent_app_type] => utility [patent_app_number] => 09/955407 [patent_app_country] => US [patent_app_date] => 2001-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 7938 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/844/06844156.pdf [firstpage_image] =>[orig_patent_app_number] => 09955407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1181358 [patent_doc_number] => 06740793 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-05-25 [patent_title] => 'Transgenic animal having a disrupted PDE7A gene and uses thereof' [patent_app_type] => B2 [patent_app_number] => 09/950920 [patent_app_country] => US [patent_app_date] => 2001-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11972 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/740/06740793.pdf [firstpage_image] =>[orig_patent_app_number] => 09950920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1171059 [patent_doc_number] => 06753456 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-06-22 [patent_title] => 'Point mutant mice with hypersensitive alpha 4 nicotinic receptors: dopaminergic pathology and increased anxiety' [patent_app_type] => B2 [patent_app_number] => 09/949298 [patent_app_country] => US [patent_app_date] => 2001-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 20 [patent_no_of_words] => 12560 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/753/06753456.pdf [firstpage_image] =>[orig_patent_app_number] => 09949298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 541612 [patent_doc_number] => 07166462 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-23 [patent_title] => 'Methods and systems for facilitating the diagnosis and treatment of schizophrenia' [patent_app_type] => utility [patent_app_number] => 09/939209 [patent_app_country] => US [patent_app_date] => 2001-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 13 [patent_no_of_words] => 15221 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/166/07166462.pdf [firstpage_image] =>[orig_patent_app_number] => 09939209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1372513 [patent_doc_number] => 06566582 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-20 [patent_title] => 'Animals with insufficient expression of uridine phosphorylase' [patent_app_type] => B1 [patent_app_number] => 09/890971 [patent_app_country] => US [patent_app_date] => 2001-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 5562 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/566/06566582.pdf [firstpage_image] =>[orig_patent_app_number] => 09890971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6778761 [patent_doc_number] => 20030049842 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Transgenic organisms having transcriptional activators with graded transactivation potential' [patent_app_type] => new [patent_app_number] => 09/922568 [patent_app_country] => US [patent_app_date] => 2001-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16715 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20030049842.pdf [firstpage_image] =>[orig_patent_app_number] => 09922568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 421820 [patent_doc_number] => 07273751 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-25 [patent_title] => 'Vascular endothelial growth factor-2' [patent_app_type] => utility [patent_app_number] => 09/921143 [patent_app_country] => US [patent_app_date] => 2001-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 68 [patent_figures_cnt] => 84 [patent_no_of_words] => 62049 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/273/07273751.pdf [firstpage_image] =>[orig_patent_app_number] => 09921143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6079859 [patent_doc_number] => 20020081284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'Manipulation of arterial-venous identity' [patent_app_type] => new [patent_app_number] => 09/921771 [patent_app_country] => US [patent_app_date] => 2001-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5025 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20020081284.pdf [firstpage_image] =>[orig_patent_app_number] => 09921771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6290187 [patent_doc_number] => 20020055169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-09 [patent_title] => 'Method for expression of heterologous proteins in yeast' [patent_app_type] => new [patent_app_number] => 09/921398 [patent_app_country] => US [patent_app_date] => 2001-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12540 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20020055169.pdf [firstpage_image] =>[orig_patent_app_number] => 09921398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1386798 [patent_doc_number] => 06537267 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-25 [patent_title] => 'Method for chronic catheterization of the common bile duct of a laboratory rat' [patent_app_type] => B1 [patent_app_number] => 09/918869 [patent_app_country] => US [patent_app_date] => 2001-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 4349 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/537/06537267.pdf [firstpage_image] =>[orig_patent_app_number] => 09918869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6033392 [patent_doc_number] => 20020019361 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-14 [patent_title] => 'Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products' [patent_app_type] => new [patent_app_number] => 09/911782 [patent_app_country] => US [patent_app_date] => 2001-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7257 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20020019361.pdf [firstpage_image] =>[orig_patent_app_number] => 09911782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5788338 [patent_doc_number] => 20020160951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder' [patent_app_type] => new [patent_app_number] => 09/909544 [patent_app_country] => US [patent_app_date] => 2001-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 25718 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20020160951.pdf [firstpage_image] =>[orig_patent_app_number] => 09909544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6529105 [patent_doc_number] => 20020192819 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Recombinational cloning using nucleic acids having recombination sites' [patent_app_type] => new [patent_app_number] => 09/907719 [patent_app_country] => US [patent_app_date] => 2001-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 58 [patent_no_of_words] => 29650 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20020192819.pdf [firstpage_image] =>[orig_patent_app_number] => 09907719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6882963 [patent_doc_number] => 20010049435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-06 [patent_title] => 'Myostatin gene promoter and inhibition of activation thereof' [patent_app_type] => new [patent_app_number] => 09/901511 [patent_app_country] => US [patent_app_date] => 2001-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4668 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20010049435.pdf [firstpage_image] =>[orig_patent_app_number] => 09901511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1157414 [patent_doc_number] => 06765126 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-07-20 [patent_title] => 'Transgenic mice containing NPY6-R neuropeptide receptor gene disruptions' [patent_app_type] => B2 [patent_app_number] => 09/900497 [patent_app_country] => US [patent_app_date] => 2001-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20083 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/765/06765126.pdf [firstpage_image] =>[orig_patent_app_number] => 09900497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6453920 [patent_doc_number] => 20020129396 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Transgenic mice containing CX2 gene disruptions' [patent_app_type] => new [patent_app_number] => 09/900518 [patent_app_country] => US [patent_app_date] => 2001-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 20262 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20020129396.pdf [firstpage_image] =>[orig_patent_app_number] => 09900518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6649830 [patent_doc_number] => 20020088018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'Transgenic mice containing MAS orphan receptor gene disruptions' [patent_app_type] => new [patent_app_number] => 09/900472 [patent_app_country] => US [patent_app_date] => 2001-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19436 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20020088018.pdf [firstpage_image] =>[orig_patent_app_number] => 09900472 [rel_patent_id] =>[rel_patent_doc_number] =>)